XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice
NCT ID: NCT02042300
Last Updated: 2025-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4000 participants
OBSERVATIONAL
2014-05-31
2024-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IRIS-Xpedition/Alpine/Sierra Cohort
XIENCE Xpedition/Alpine/Sierra
XIENCE Xpedition/Alpine/Sierra
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
XIENCE Xpedition/Alpine/Sierra
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent
* Agreed with written informed consent form
Exclusion Criteria
* Life expectancy of 1year and under
* Cardiac shock
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioVascular Research Foundation, Korea
OTHER
Abbott
INDUSTRY
Seung-Jung Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jung Park
MD,PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hallym University Sacred Heart Hospital
Anyang, , South Korea
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, , South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, , South Korea
Gangwon National Univ. Hospital
Chuncheon, , South Korea
Daegu Catholic University Medical Center
Daegu, , South Korea
Keimyung University Dongsan Medical Center
Daegu, , South Korea
Yeungnam University Medical Center
Daegu, , South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, , South Korea
Gangneung Asan Hospital
Gangneung, , South Korea
Chonnam National University Hospital
Gwangju, , South Korea
Gachon University Gil Hospital
Incheon, , South Korea
Inha University Hospital
Incheon, , South Korea
ChonBuk National University Hospital
Jeonju, , South Korea
Kwangju Christian Hospital
Kwangju, , South Korea
Dong-A Medical Center
Pusan, , South Korea
Inje University HAEUNDAE Paik Hospital
Pusan, , South Korea
Inje University Pusan Paik Hospital
Pusan, , South Korea
Pusan National University Hospital
Pusan, , South Korea
Asan Medical Center
Seoul, , South Korea
Korea University Guro Hospital
Seoul, , South Korea
Seoul Veterans Hospital
Seoul, , South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, , South Korea
The Catholic University of Korea, Yeouido St. Mary's Hospital
Seoul, , South Korea
The Catholic University of Korea Uijeongbu St. Mary's Hospital
Uijeongbu-si, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Pusan National University Yangsan Hospital
Yangsan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCCV2013-11
Identifier Type: -
Identifier Source: org_study_id